A detailed history of Delaney Dennis R transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Delaney Dennis R holds 2,865 shares of VRTX stock, worth $1.39 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
2,865
Previous 1,238 131.42%
Holding current value
$1.39 Million
Previous $517,000 159.57%
% of portfolio
0.73%
Previous 0.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $639,101 - $789,957
1,627 Added 131.42%
2,865 $1.34 Million
Q1 2024

May 03, 2024

BUY
$407.69 - $446.08 $504,720 - $552,247
1,238 New
1,238 $517,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $125B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Delaney Dennis R Portfolio

Follow Delaney Dennis R and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delaney Dennis R, based on Form 13F filings with the SEC.

News

Stay updated on Delaney Dennis R with notifications on news.